Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05174767 · ClinicalTrials.gov registry record · NA
PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
A NA study of Acute Aortic Dissection, sponsored by Artivion.
- Active
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 20
- Study locations
NCT05174767 is a NA study of Acute Aortic Dissection that is active but no longer recruiting, run by Artivion. The registered enrollment target is 115 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT05174767, a NA study of Acute Aortic Dissection, is active but no longer recruiting, sponsored by Artivion.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, non-randomized, multicenter clinical investigation to assess the safety and effectiveness of AMDS in the treatment of patients with acute DeBakey type I dissection, with evidence of malperfusion, through open surgical repair.
Conditions Studied
Interventions
- DEVICE AMDS
Study Locations (20)
New York
- Mount Sinai Hospital - New York
- Columbia University Irving Medical Center/New York Presbyterian Hospital - New York
- Northwell - New York
- Montefiore Einstein Medical - The Bronx
California
- University of Southern California - Los Angeles
- Stanford University - Palo Alto
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- University of Colorado - Aurora
Connecticut
- Hartford Hospital - Hartford
Florida
- University of Florida - Gainesville
Georgia
- Emory University Medical Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2022-05-27 |
| Est. Completion | 2029-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05174767
The ClinicalTrials.gov registry entry for NCT05174767 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Artivion, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Aortic Dissection appearing as the primary indexed condition, and to 1 intervention - of which AMDS is the first listed.
NCT05174767 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05174767 about?
NCT05174767 is a clinical study titled "PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection". Prospective, non-randomized, multicenter clinical investigation to assess the safety and effectiveness of AMDS in the treatment of patients with acute DeBakey type I dissection, with evidence of malperfusion, through open surgical repair.
What is the current status of trial NCT05174767?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 115 participants. The study started on 2022-05-27. Estimated completion is 2029-12-06.
What conditions does trial NCT05174767 study?
This clinical trial studies the following conditions: Acute Aortic Dissection.
What interventions are being tested in trial NCT05174767?
The interventions under investigation include: AMDS (DEVICE).
Who is sponsoring clinical trial NCT05174767?
This trial is sponsored by Artivion, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05174767 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Aortic Dissection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.